Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients

被引:17
作者
GrossWeege, W [1 ]
Dumon, K [1 ]
Dahmen, A [1 ]
Schneider, EM [1 ]
Roher, HD [1 ]
机构
[1] UNIV DUSSELDORF,INST HAMOSTASEOL & TRANSFUS MED,D-40225 DUSSELDORF,GERMANY
关键词
D O I
10.1007/BF01713146
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
The granulocyte colony-stimulating factor (G-CSF) regulates neutrophil differentiation and function. Serum levels of G-CSF increase during acute infectious processes. The levels of G-CSF were measured in 59 surgical intensive care unit (ICU) patients. In general, G-CSF was only elevated during the first 2 days after admission to the ICU. Higher G-CSF levels were more frequently observed in patients without infectious complications and in patients who survived. Later on, G-CSF levels were below 100 pg/ml in almost all patients studied. The highest G-CSF level (20,000 pg/ml) was observed in one patient with septic shock 36 h after leukopenia. The patient recovered from septic shock and multiple organ failure and was discharged. It is proposed that surgical ICU patients,vith low or undetectable G-CSF serum levels may benefit from exogenous G-CSF substitution protocols.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 17 条
[1]
AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[2]
Cebon J, 1994, Curr Opin Hematol, V1, P228
[3]
SHOCK AND MULTIPLE-ORGAN DYSFUNCTION AFTER SELF-ADMINISTRATION OF SALMONELLA ENDOTOXIN [J].
DASILVA, AMT ;
KAULBACH, HC ;
CHUIDIAN, FS ;
LAMBERT, DR ;
SUFFREDINI, AF ;
DANNER, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (20) :1457-1460
[4]
DEMETRI GD, 1991, BLOOD, V78, P2791
[5]
CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[6]
GORGEN I, 1992, J IMMUNOL, V149, P918
[7]
EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR TREATMENT ON EX-VIVO BLOOD CYTOKINE RESPONSE IN HUMAN VOLUNTEERS [J].
HARTUNG, T ;
DOCKE, WD ;
GANTNER, F ;
KRIEGER, G ;
SAUER, A ;
STEVENS, P ;
VOLK, HD ;
WENDEL, A .
BLOOD, 1995, 85 (09) :2482-2489
[8]
KAWAKAMI M, 1990, BLOOD, V76, P1962
[9]
THE APACHE-III PROGNOSTIC SYSTEM - RISK PREDICTION OF HOSPITAL MORTALITY FOR CRITICALLY ILL HOSPITALIZED ADULTS [J].
KNAUS, WA ;
WAGNER, DP ;
DRAPER, EA ;
ZIMMERMAN, JE ;
BERGNER, M ;
BASTOS, PG ;
SIRIO, CA ;
MURPHY, DJ ;
LOTRING, T ;
DAMIANO, A ;
HARRELL, FE .
CHEST, 1991, 100 (06) :1619-1636
[10]
INCREASED CIRCULATING CYTOKINES, CYTOKINE ANTAGONISTS, AND E-SELECTIN AFTER INTRAVENOUS ADMINISTRATION OF ENDOTOXIN IN HUMANS [J].
KUHNS, DB ;
ALVORD, WG ;
GALLIN, JI .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :145-152